Stryker Could Bid for Smith & Nephew Soon
This article was originally published in The Gray Sheet
Stryker may make bid for Smith and Nephew this week in a deal that would be completed by end of next year, according to analysts. While the deal makes strategic sense, analysts warn it could carry higher regulatory risk.
You may also be interested in...
In spite of increasing price pressure, the $9 billion global spine market is projected to see low-single-digit growth in the next few years. Driving growth are the pure-play spine companies targeting high-growth segments such as minimally invasive surgery, expandable interbody cases, cervical discs, and deformity.
The company says the buy will expand its portfolio to include low-height hospital beds that are safer for patients.
Zimmer has agreed to buy Biomet by the first quarter of 2015, furthering the trend of consolidation in the $45 billion orthopedic device industry. The companies had combined revenues of $7.8 billion in 2013.